Overview

Botulinum for Chronic Exertional Compartment Syndrome

Status:
Terminated
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
We will investigate the feasibility of a simple outpatient one time injection regimen for the treatment of Chronic Exertional Compartment Syndrome (CECS). We think botulinum toxin injections will be a potentially cost-effective, low-risk alternative to surgery in reducing pain and returning patients to full activity.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
375th Medical Group, Scott Air Force Base
Treatments:
Botulinum Toxins